The 20 Best Leukoplakia Doctors in Maryland, US

Lee Akst, M.D., specializes in treating the larynx (voicebox), in particular the treatment of voice and swallowing disorders. He is a leading laryngologist in office-based procedures such as vocal fold injection augmentation, pulsed KTP laser treatment, and laryngeal botox injection. In the operating room, Dr. Akst specializes in phonosurgery for the treatment of vocal cord disease, with emphasis on voice restoration and improvement. A strong focus of his practice involves the use of pulsed angiolytic lasers, which allow for subspecialized care of laryngeal papillomas, laryngeal dysplasia, and early vocal cord cancers while preserving the quality and strength of the voice. Dr. Akst is a national leader in the field of laryngology and serves in leadership roles for the American Laryngological Association, the American Broncho-Esophagological Association, and the American Academy of Otolaryngology-Head and Neck Surgery. He lectures extensively on the treatment of laryngeal disease, teaching other physicians how to care for patients with voice and swallowing concerns. His research interests include the development of robotic laryngeal surgery, the study of voice and swallowing complaints in the elderly, and the advancement of pulsed lasers for the treatment of laryngeal diseases with a focus on leukoplakia. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Akst is rated as an Advanced provider by MediFind in the treatment of Leukoplakia. His top areas of expertise are Spasmodic Dysphonia, Laryngitis, Perichondritis, Endoscopy, and Laryngectomy.

Wayne Koch is a national and international leader in head and neck oncologic surgery, caring for patients with cancers of the oral cavity, salivary gland, larynx, hypopharynx, oropharynx and thyroid. Among Dr. Koch's landmark publications are studies demonstrating how key molecular events such as p53 mutation and human papillomavirus (HPV) contribute to the development of head and neck cancer. His peer-reviewed publications include six articles in the New England Journal of Medicine. Dr. Koch is also involved in humanitarian outreach focused on training surgeons in several African nations. He has served as president of the American Head and Neck Society, the national organization of head and neck cancer surgeons in the USA. Dr. Koch is rated as an Advanced provider by MediFind in the treatment of Leukoplakia. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Human Papillomavirus Infection, Laryngectomy, and Gastrostomy.

Timothy Meiller is an Oral and Maxillofacial Surgeon and a General Surgeon in Baltimore, Maryland. Dr. Meiller has been practicing medicine for over 47 years and is rated as a Distinguished provider by MediFind in the treatment of Leukoplakia. His top areas of expertise are Mouth Ulcers, Mouth Sores, Leukoplakia, and Pyogenic Granuloma. Dr. Meiller is currently accepting new patients.

Joshua Lubek is an Oral and Maxillofacial Surgeon in Baltimore, Maryland. Dr. Lubek is rated as a Distinguished provider by MediFind in the treatment of Leukoplakia. His top areas of expertise are Tongue Cancer, Oral Squamous Cell Carcinoma, Leukoplakia, Gastrostomy, and Glossectomy.

Donita Dyalram is an Oral and Maxillofacial Surgeon in Baltimore, Maryland. Dr. Dyalram is rated as a Distinguished provider by MediFind in the treatment of Leukoplakia. Her top areas of expertise are Tongue Cancer, Leukoplakia, Osteochondroma, Gastrostomy, and Tissue Biopsy.

Maie John is an Otolaryngologist in Baltimore, Maryland. Dr. John is rated as an Experienced provider by MediFind in the treatment of Leukoplakia. Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Melanoma, Glossectomy, and Gastrostomy.

Dr. Carole Fakhry is a head and neck surgical oncologist at Johns Hopkins and treats the breadth of patients with head and neck cancers, including cancers of the tonsils, base of tongue, mouth, larynx, thyroid, salivary gland (parotid, submandibular gland) and skin cancers among others. She is the Chief of the Division of Head and Neck Surgery and Director of the Head and Neck Cancer Center. She also serves as director of the head and neck group in the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the head and neck surgical oncology fellowship. She is the associate editor for Oral Oncology and serves on several editorial boards. After an undergraduate degree at Stanford University, she completed medical school, residency in otolaryngology head and neck surgery, and a fellowship in head and neck surgical oncology at Johns Hopkins. She has also received a master’s in public health from the Johns Hopkins Bloomberg School of Public Health. She is presently a professor in the Johns Hopkins Department of Otolaryngology-Head and Neck Surgery, Oncology, and Johns Hopkins Bloomberg School of Public Health Department of Epidemiology. Her research interest focuses on the role of human papillomavirus (HPV) in head and neck squamous cell cancer. She has demonstrated that the presence of HPV confers a prognostic advantage to individuals with oropharyngeal cancer and that HPV is associated with unique clinical characteristics. In addition to the clinical implications of HPV in head and neck cancer, she is co-principal investigator of a large study to understand screening individuals at “high risk” of malignancy and evaluating imaging modalities to improve diagnostics and early detection of HPV- related head and neck cancer. Dr. Fakhry is rated as an Experienced provider by MediFind in the treatment of Leukoplakia. Her top areas of expertise are Human Papillomavirus Infection, Head and Neck Squamous Cell Carcinoma (HNSCC), Salivary Gland Tumors, Laryngectomy, and Gastrostomy.

Christine Gourin, M.D. M.P.H., is a head and neck surgical oncologist and palliative medicine specialist who treats patients with head and neck tumors, including tumors of the skin, melanoma, oral cavity, larynx, oropharynx, neck, salivary glands, sinuses, and skull base. Dr. Gourin received her medical degree from the State University of New York-Health Science Center at Brooklyn/Downstate Medical Center. Dr. Gourin trained in General Surgery and Otolaryngology-Head and Neck Surgery at the University of Vermont, followed by a fellowship in Advanced Head and Neck Oncologic Surgery at the University of Pittsburgh and a fellowship in Hospice and Palliative Medicine at Johns Hopkins University. She has authored over 200 peer-reviewed journal articles, 24 book chapters and two books: Medical and Surgical Management of Thyroid and Parathyroid Diseases and The Johns Hopkins Patient Guide to Head and Neck Cancer. She is on the Editorial Board of The Laryngoscope and is a reviewer for numerous other head and neck surgery journals. Dr. Gourin is a nationally and internationally recognized expert in quality of care and outcomes with a lifelong interest in improved symptom management, communication, access to high-quality affordable care, and palliative medicine in head and neck cancer. She has an active head and neck surgical oncology practice and has been named to America’s Top Physicians and Best Doctors in America annually since 2005. She is the Director of the Johns Hopkins Head and Neck Cancer Supportive Care Clinic. Dr. Gourin is rated as an Experienced provider by MediFind in the treatment of Leukoplakia. Her top areas of expertise are Laryngeal Cancer, Throat Cancer, Tongue Cancer, Laryngectomy, and Gastrostomy.

Nyall London has a unique clinical practice focused on the care of patients with sinonasal and skull base cancers. As one of the few surgeons trained in both head and neck cancer surgery, as well as rhinology and skull base surgery, he offers patients comprehensive sinonasal tumor surgical care, including open and endoscopic approaches as well as neck dissection surgery. Dr. London has developed notable patient education events about the multidisciplinary and long-term care of patients with sinonasal malignancies. Additionally, he is an innovator of clinical trials for these rare tumors, with open clinical trial options available and multiple others in development. Internationally recognized for his expertise in the care of patients with sinonasal and skull base cancers, Dr. London was an associate editor for the first international consensus statement on sinonasal tumors, and was appointed president of the International Network for Sinonasal Cancer Research (2024–26). He directs a research laboratory at the National Cancer Institute/National Institutes of Health focused on therapeutic advances and mechanisms of sinonasal tumorigenesis. Dr. London has published more than 130 peer-reviewed research articles, reviews and book chapters, including co-first author publications in Nature, Nature Medicine, Science Translational Medicine and Nature Cell Biology. He earned his medical and doctoral degrees from the University of Utah, and completed his residency in otolaryngology–head and neck surgery at Johns Hopkins. He also accomplished a fellowship in open and endoscopic head and neck and skull base surgery at The Ohio State University, under the direction of Dr. Ricardo Carrau. Dr. London is rated as an Experienced provider by MediFind in the treatment of Leukoplakia. His top areas of expertise are Olfactory Neuroblastoma, Sinus Cancer, Teratocarcinosarcoma, Endoscopy, and Craniectomy.

Wojtek Mydlarz, director of Johns Hopkins Head and Neck Surgery in the National Capital Region, specializes in the treatment of benign and malignant tumors of the head and neck, including the upper aerodigestive tract, salivary glands, skull base, thyroid, skin and soft tissue. Dr. Mydlarz is a medical officer and a clinical and research collaborator in the head and neck surgery branch of the National Institutes of Health (NIH). His research interests include evaluating both surgical and nonsurgical treatment outcomes in patients with head and neck cancer. He is interested in the complex molecular biology of head and neck cancer, as well as potential clinical applications of novel targeted cancer therapies. He is actively involved in clinical trial development and implementation at the NIH and Johns Hopkins. After earning his medical degree from the Johns Hopkins University School of Medicine, Dr. Mydlarz completed his internship and residency in otolaryngology–head and neck surgery at The Johns Hopkins Hospital. Additionally, he completed a Science of Clinical Investigation Training Program at Johns Hopkins Bloomberg School of Public Health and specialized fellowship training in head and neck surgical oncology at the University of Texas MD Anderson Cancer Center. Dr. Mydlarz has contributed to numerous professional publications, authored a variety of articles and book chapters, and has been invited to give many lectures. He serves on the editorial board for Oral Oncology and Laryngoscope Investigative Otolaryngology, and is a journal reviewer for Oral Oncology, Head and Neck, Laryngoscope and JAMA Otolaryngology–Head and Neck Surgery. Dr. Mydlarz is rated as an Experienced provider by MediFind in the treatment of Leukoplakia. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Salivary Gland Tumors, Laryngectomy, and Glossectomy.

Pryor Brenner is an Otolaryngologist in Chevy Chase, Maryland. Dr. Brenner is rated as an Experienced provider by MediFind in the treatment of Leukoplakia. His top areas of expertise are Jones Syndrome, DFNB1, Infant Hearing Loss, and Benign Paroxysmal Positional Vertigo.

Robert Ord is an Oral and Maxillofacial Surgeon in Baltimore, Maryland. Dr. Ord is rated as an Advanced provider by MediFind in the treatment of Leukoplakia. His top areas of expertise are Tongue Cancer, Erythroplakia, Leukoplakia, Glossectomy, and Gastrostomy.

Lorie Cram is a primary care provider, practicing in Family Medicine in White Plains, Maryland. Dr. Cram is rated as an Experienced provider by MediFind in the treatment of Leukoplakia. Her top areas of expertise are Enlarged Liver, Hypertensive Heart Disease, Pediatric Myocarditis, and Nephrosclerosis.

Andrew Day is a Plastic Surgeon and an Otolaryngologist in Baltimore, Maryland. Dr. Day is rated as an Experienced provider by MediFind in the treatment of Leukoplakia. His top areas of expertise are Tongue Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngeal Cancer, Tissue Biopsy, and Gastrostomy.

Julie Winston is a Plastic Surgeon and an Otolaryngologist in Towson, Maryland. Dr. Winston is rated as an Experienced provider by MediFind in the treatment of Leukoplakia. Her top areas of expertise are Nasal Polyps, Laryngeal Nerve Damage, Vocal Cord Dysfunction, and Spasmodic Dysphonia.

Allen Friedman is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Friedman is rated as an Experienced provider by MediFind in the treatment of Leukoplakia. His top areas of expertise are Leukoplakia, Type 2 Diabetes (T2D), Erythroplakia, and Maturity Onset Diabetes of the Young.

Robert Jackson is a General Surgeon in Frederick, Maryland. Dr. Jackson is rated as an Experienced provider by MediFind in the treatment of Leukoplakia. His top areas of expertise are DFNB1, Infant Hearing Loss, Jones Syndrome, and Otitis.

Craig Gold is a primary care provider, practicing in Internal Medicine in Pikesville, Maryland. Dr. Gold is rated as an Experienced provider by MediFind in the treatment of Leukoplakia. His top areas of expertise are Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and High Cholesterol.

Carolyn Hammett is an Internal Medicine provider in Laurel, Maryland. Dr. Hammett is rated as an Experienced provider by MediFind in the treatment of Leukoplakia. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Adenoid Cystic Carcinoma, Salivary Gland Tumors, and Polymorphous Low Grade Adenocarcinoma.

Jong Yoon is a General Surgeon in Frederick, Maryland. Dr. Yoon is rated as an Experienced provider by MediFind in the treatment of Leukoplakia. His top areas of expertise are Infant Hearing Loss, DFNB1, Jones Syndrome, and Otitis.